4.5 Article

Radiation Exposure From Pediatric CT Scans and Subsequent Cancer Risk in the Netherlands

Journal

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
Volume 111, Issue 3, Pages 256-263

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/jnci/djy104

Keywords

-

Categories

Funding

  1. European Community [269912-EPI-CT]
  2. Worldwide Cancer Research [12-1155]
  3. Dutch Cancer Society

Ask authors/readers for more resources

Background Computed tomography (CT), a strong diagnostic tool, delivers higher radiation doses than most imaging modalities. As CT use has increased rapidly, radiation protection is important, particularly among children. We evaluate leukemia and brain tumor risk following exposure to low-dose ionizing radiation from CT scans in childhood. Methods For a nationwide retrospective cohort of 168394 children who received one or more CT scans in a Dutch hospital between 1979 and 2012 who were younger than age 18 years, we obtained cancer incidence, vital status, and confounder information by record linkage with external registries. Standardized incidence ratios were calculated using cancer incidence rates from the general Dutch population. Excess relative risks (ERRs) per 100 mGy organ dose were calculated with Poisson regression. All statistical tests were two-sided. Results Standardized incidence ratios were elevated for all cancer sites. Mean cumulative bone marrow doses were 9.5 mGy at the end of follow-up, and leukemia risk (excluding myelodysplastic syndrome) was not associated with cumulative bone marrow dose (44 cases). Cumulative brain dose was on average 38.5 mGy and was statistically significantly associated with risk for malignant and nonmalignant brain tumors combined (ERR/100 mGy: 0.86, 95% confidence interval = 0.20 to 2.22, P = .002, 84 cases). Excluding tuberous sclerosis complex patients did not substantially change the risk. Conclusions We found evidence that CT-related radiation exposure increases brain tumor risk. No association was observed for leukemia. Compared with the general population, incidence of brain tumors was higher in the cohort of children with CT scans, requiring cautious interpretation of the findings.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy

Vincent M. T. de Jong, Yuwei Wang, Natalie D. ter Hoeve, Mark Opdam, Nikolas Stathonikos, Katarzyna Jozwiak, Michael Hauptmann, Sten Cornelissen, Willem Vreuls, Efraim H. Rosenberg, Esther A. Koop, Zsuzsanna Varga, Carolien H. M. van Deurzen, Antien L. Mooyaart, Alicia Cordoba, Emma J. Groen, Joost Bart, Stefan M. Willems, Vasiliki Zolota, Jelle Wesseling, Anna Sapino, Ewa Chmielik, Ales Ryska, Annegien Broeks, Adri C. Voogd, Sherene Loi, Stefan Michiels, Gabe S. Sonke, Elsken van der Wall, Sabine Siesling, Paul J. van Diest, Marjanka K. Schmidt, Marleen Kok, Gwen M. H. E. Dackus, Roberto Salgado, Sabine C. Linn

Summary: High sTILs (>= 75%) in young patients with chemotherapy-naive N0 TNBC indicate an excellent long-term prognosis, suggesting the consideration of sTILs in prospective clinical trials exploring (neo)adjuvant chemotherapy de-escalation strategies.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Oncology

Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance in HR+/HP2-Early Breast Cancer

Ulrike A. Nitz, Oleg Gluz, Sherko Kuemmel, Matthias Christgen, Michael Braun, Bahriye Aktas, Kerstin Luedtke-Heckenkamp, Helmut Forstbauer, Eva-Maria Grischke, Claudia Schumacher, Maren Darsow, Katja Krauss, Benno Nuding, Marc Thill, Jochem Potenberg, Christoph Uleer, Mathias Warm, Hans Holger Fischer, Wolfram Malter, Michael Hauptmann, Ronald E. Kates, Monika Graeser, Rachel Wuerstlein, Steven Shak, Frederick Baehner, Hans H. Kreipe, Nadia Harbeck

Summary: The WSG-ADAPT-HR+/HER2- study demonstrates the feasibility of guiding systemic treatment for breast cancer using both the recurrence score (RS) and endocrine therapy (ET) response, and avoids the use of chemotherapy in pre- and postmenopausal patients with <= 3 involved lymph nodes.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Oncology

Radiotherapy-Related Dose and Irradiated Volume Effects on Breast Cancer Risk Among Hodgkin Lymphoma Survivors

Sander Roberti, Flora E. van Leeuwen, Cecile M. Ronckers, Inge M. Krul, Florent de Vathaire, Cristina Veres, Ibrahima Diallo, Cecile P. M. Janus, Berthe M. P. Aleman, Nicola S. Russell, Michael Hauptmann

Summary: The study found that mean breast dose predicts the risk of subsequent breast cancer in long-term HL survivors.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)

Article Respiratory System

European Respiratory Society guideline on various aspects of quality in lung cancer care

Torsten Gerriet Blum, Rebecca L. Morgan, Valerie Durieux, Joanna Chorostowska-Wynimko, David R. Baldwin, Jeanette Boyd, Corinne Faivre-Finn, Francoise Galateau-Salle, Fernando Gamarra, Bogdan Grigoriu, Georgia Hardavella, Michael Hauptmann, Erik Jakobsen, Dragana Jovanovic, Paul Knaut, Gilbert Massard, John McPhelim, Anne-Pascale Meert, Robert Milroy, Riccardo Muhr, Luciano Mutti, Marianne Paesmans, Pippa Powell, Paul Martin Putora, Janette Rawlinson, Anna L. Rich, David Rigau, Dirk de Ruysscher, Jean-Paul Sculier, Arnaud Schepereel, Dragan Subotic, Paul Van Schil, Thomy Tonia, Clare Williams, Thierry Berghmans

Summary: This guideline provides good quality recommendations in lung cancer care, based on systematic reviews and evidence syntheses. The recommendations cover various quality improvement measures, such as avoiding delays in diagnosis and treatment, integrating multidisciplinary teams, adhering to guidelines, and using specific tools for decision-making. The recommendations should be periodically updated as new evidence becomes available.

EUROPEAN RESPIRATORY JOURNAL (2023)

Article Oncology

Brain cancer after radiation exposure from CT examinations of children and young adults: results from the EPI-CT cohort study

Michael Hauptmann, Graham Byrnes, Elisabeth Cardis, Marie-Odile Bernier, Maria Blettner, Jeremie Dabin, Hilde Engels, Tore S. Istad, Christoffer Johansen, Magnus Kaijser, Kristina Kjaerheim, Neige Journy, Johanna M. Meulepas, Monika Moissonnier, Cecile Ronckers, Isabelle Thierry-Chef, Lucian Le Cornet, Andreas Jahnen, Roman Pokora, Magda Bosch de Basea, Jordi Figuerola, Carlo Maccia, Arvid Nordenskjold, Richard W. Harbron, Choonsik Lee, Steven L. Simon, Amy Berrington de Gonzalez, Joachim Schuz, Ausrele Kesminiene

Summary: The European EPI-CT study aims to assess the risk of brain cancer from CT examinations in children and young adults. Using data from nine European countries, the study found a significant dose-response relationship between CT-related radiation exposure and brain cancer.

LANCET ONCOLOGY (2023)

Article Oncology

Temporal patterns of childhood cancer survival 1991 to 2016: A nationwide register-study based on data from the German Childhood Cancer Registry

Maike Wellbrock, Claudia Spix, Cecile M. Ronckers, Desiree Grabow, Anna-Liesa Filbert, Arndt Borkhardt, Daniel Wollschlaeger, Friederike Erdmann

Summary: Childhood cancer is the leading cause of death among children under 15 in Europe. A long-term assessment of childhood cancer survival in Germany from 1991 to 2016 showed overall improvement in survival rates, but recent progress has slowed down and some cancer types have reached a plateau in survival rates.

INTERNATIONAL JOURNAL OF CANCER (2023)

Article Oncology

De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR1/HER21 Early Breast Cancer: 5-Year Survival in the WSG-ADAPT-TP Trial

Nadia Harbeck, Ulrike A. Nitz, Matthias Christgen, Sherko Kuemmel, Michael Braun, Claudia Schumacher, Jochem Potenberg, Joke Tio, Bahriye Aktas, Helmut Forstbauer, Eva-Maria Grischke, Iris Scheffen, Wolfram Malter, Raquel von Schumann, Marianne Just, Christine zu Eulenburg, Claudia Biehl, Cornelia Kolberg-Liedtke, Regula Deurloo, Sanne de Haas, Katarzyna Jozwiak, Michael Hauptmann, Ronald Kates, Monika Graeser, Rachel Wuerstlein, Hans H. Kreipe, Oleg Gluz

Summary: The WSG-ADAPT-TP trial demonstrated that pathological complete response (pCR) after 12 weeks of chemotherapy-free de-escalated neoadjuvant therapy was associated with excellent survival in hormone receptor-positive/human epidermal growth factor receptor 2-positive early breast cancer (HR+/HER2+ EBC) without further adjuvant chemotherapy (ACT). Patients with pCR had similar 5-year invasive disease-free survival (iDFS) rates whether or not they received ACT. Patient selection based on biomarkers or molecular subtypes may improve efficacy of HER2-targeted approaches without systemic chemotherapy.

JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Medicine, Research & Experimental

NT-proBNP/urine hepcidin-25 ratio and cardiorenal syndrome type 1 in patients with severe symptomatic aortic stenosis

Jonathan Nuebel, Meike Hoffmeister, Oliver Labrenz, Kerstin Jost, Stefanie Oess, Michael Hauptmann, Julika Schoen, Georg Fritz, Michael Haase, Christian Butter, Anja Haase-Fielitz

Summary: This study aimed to determine whether novel and conventional cardiorenal biomarkers in patients before transcatheter aortic valve implantation may be associated with cardiorenal syndrome (CRS) type 1. Serum NT-proBNP and urine biomarkers (hepcidin-25, NGAL, IL-6) were measured, and it was found that patients with CRS type 1 had longer hospital stay and had higher readmission rate within 6 months after discharge. The NT-proBNP/urine hepcidin-25 ratio was identified as an independent modifier of CRS type 1.

BIOMARKERS IN MEDICINE (2023)

Review Health Care Sciences & Services

A scoping review of statistical methods in studies of biomarker-related treatment heterogeneity for breast cancer

L. Sollfrank, S. C. Linn, M. Hauptmann, K. Jozwiak

Summary: This study aimed to explore the commonly used biomarker-based tests in clinical studies, and found that most studies evaluated treatment heterogeneity by analyzing biomarker-specific treatment effects and/or multiplicative interaction. However, there is a need for more efficient statistical methods to evaluate treatment heterogeneity in clinical studies.

BMC MEDICAL RESEARCH METHODOLOGY (2023)

Article Biochemistry & Molecular Biology

Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancer

Yuehan Wang, Cecile M. Ronckers, Flora E. van Leeuwen, Chaya S. Moskowitz, Wendy Leisenring, Gregory T. Armstrong, Florent de Vathaire, Melissa M. Hudson, Claudia E. Kuehni, Michael A. Arnold, Charlotte Demoor-Goldschmidt, Daniel M. Green, Tara O. Henderson, Rebecca M. Howell, Matthew J. Ehrhardt, Joseph P. Neglia, Kevin C. Oeffinger, Helena J. H. van der Pal, Leslie L. Robison, Michael Schaapveld, Lucie M. Turcotte, Nicolas Waespe, Nadia Haddy, Ibrahima Diallo, K. Scott Baker, Amy Berrington de Gonzalez, Miriam R. Conces, Louis S. Constine, Mike Hawkins, Jacqueline J. Loonen, Marloes Louwerens, Geert O. Janssens, Lene Mellemkjaer, Raoul Reulen, Jeanette F. Winther, Leontien C. M. Kremer, Jop C. Teepen

Summary: In this study, the association between anthracycline-based chemotherapy and subsequent breast cancer risk in female childhood cancer survivors was investigated. The findings suggest that there is a dose-dependent increased risk of subsequent breast cancer associated with doxorubicin, with a more than twofold increased risk for survivors treated with a cumulative doxorubicin dose of 200 mg/m² or higher. Early initiation of breast cancer surveillance may be reasonable for these survivors.

NATURE MEDICINE (2023)

Review Orthopedics

Cannulated screws versus dynamic hip screw versus hemiarthroplasty versus total hip arthroplasty in patients with displaced and non-displaced femoral neck fractures: a systematic review and frequentist network meta-analysis of 5703 patients

Nikolai Ramadanov, Katarzyna Jozwiak, Michael Hauptmann, Philip Lazaru, Polina Marinova-Kichikova, Dobromir Dimitrov, Roland Becker

Summary: This study compared cannulated screw fixation, dynamic hip screw fixation, hemiarthroplasty, and total hip arthroplasty in patients with displaced or non-displaced femoral neck fracture, evaluating surgical and functional outcomes, reoperation rates, and postoperative complications. The results showed that total hip arthroplasty and hemiarthroplasty were superior to cannulated screw fixation and dynamic hip screw fixation in terms of life quality and functional outcomes. Thus, hip arthroplasty should be preferred over internal fixation for femoral neck fractures, with internal fixation considered only in individual cases.

JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH (2023)

Article Cardiac & Cardiovascular Systems

App-based assessment of memory functions in patients after transfemoral aortic valve replacement

Jonathan Nubel, Michael Hauptmann, Julika Schoen, Georg Fritz, Christian Butter, Anja Haase-Fielitz

Summary: This study aimed to assess the neurocognitive function before and after transfemoral aortic valve replacement. The results showed that preoperative memory function was below average, while there was an improvement in memory function after the procedure. However, there were no changes in the digit span test.

JOURNAL OF GERIATRIC CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Association between Neuron-Specific Enolase, Memory Function, and Postoperative Delirium after Transfemoral Aortic Valve Replacement

Jonathan Nuebel, Charlotte Buhre, Meike Hoffmeister, Stefanie Oess, Oliver Labrenz, Kerstin Jost, Michael Hauptmann, Julika Schoen, Georg Fritz, Christian Butter, Anja Haase-Fielitz

Summary: This study found that changes in neuron-specific enolase (NSE) levels after TAVR did not significantly impair memory function, but patients with postoperative delirium (POD) had significantly higher levels of NSE.

JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE (2023)

Article Oncology

The cumulative burden of self-reported, clinically relevant outcomes in long-term childhood cancer survivors and implications for survivorship care: A DCCSS LATER study

Nina Streefkerk, Jop C. Teepen, Elizabeth A. M. Feijen, Katarzyna Jozwiak, Helena J. H. van der Pal, Cecile M. Ronckers, Andrica C. H. De Vries, Margriet van der van der Loo, Nynke Hollema, Marleen van den Berg, Jacqueline Loonen, Martha A. Grootenhuis, Dorine Bresters, A. Brigitta Versluys, Eline van Dulmen-den Broeder, Marry M. van den Heuvel-eibrink, Flora E. van Leeuwen, Sebastian J. C. M. M. Neggers, Hanneke M. Van Santen, Mike Hawkins, Michael Hauptmann, Daisuke Yoneoka, Joke C. Korevaar, Wim J. E. Tissing, Leontien C. M. Kremer

Summary: This study found that childhood cancer survivors experience a high cumulative burden of clinically relevant outcomes compared to siblings. The burden mainly consists of endocrine and vascular conditions and varies by primary cancer type. However, the ranking of 30-year MCC often does not correspond with levels of care in existing risk stratifications.

CANCER (2023)

Article Oncology

External validation and clinical utility assessment of PREDICT breast cancer prognostic model in young, systemic treatment-naïve women with node-negative breast cancer

Yuwei Wang, Annegien Broeks, Daniele Giardiello, Michael Hauptmann, Katarzyna Jozwiak, Esther A. Koop, Mark Opdam, Sabine Siesling, Gabe S. Sonke, Nikolas Stathonikos, Natalie D. ter Hoeve, Elsken van der Wall, Carolien H. M. van Deurzen, Paul J. van Diest, Adri C. Voogd, Willem Vreuls, Sabine C. Linn, Gwen M. H. E. Dackus, Marjanka K. Schmidt

Summary: This study validated the reliability of the PREDICT breast cancer prognostic model and assessed its clinical utility in young women with node-negative breast cancer. The results showed that PREDICT was not reliable in predicting outcomes for this patient subset and further updates are needed.

EUROPEAN JOURNAL OF CANCER (2023)

No Data Available